Inventor
PRICKETT KATHRYN S
US33 patents
⚠️ This page may combine multiple inventors who share the name “PRICKETT KATHRYN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMYLIN PHARMACEUTICALS INC
21 patentsUS7297761B2Nov 20, 2007
Pharmaceutical compositions containing exendins
AMYLIN PHARMACEUTICALS INC114 citations99
US7138375B2Nov 21, 2006
Use of exendins and agonists thereof for lowering plasma lipid
AMYLIN PHARMACEUTICALS INC95 citations99
US7115569B2Oct 3, 2006
Exendins, exendin agonists, and methods for their use
AMYLIN PHARMACEUTICALS INC114 citations99
US6989366B2Jan 24, 2006
Exendins, exendin agonists, and methods for their use
AMYLIN PHARMACEUTICALS INC111 citations99
US6924264B1Aug 2, 2005
Modified exendins and exendin agonists
AMYLIN PHARMACEUTICALS INC169 citations99
US6858576B1Feb 22, 2005
Methods for regulating gastrointestinal motility
AMYLIN PHARMACEUTICALS INC211 citations99
US7691963B2Apr 6, 2010
Exendins and exendin agonists modified with polyamino acids
AMYLIN PHARMACEUTICALS INC48 citations98
US6087334AJul 11, 2000
Anti-diabetic peptides
AMYLIN PHARMACEUTICALS INC118 citations98
US7928065B2Apr 19, 2011
Methods of treatment using exendin peptides or GLP-1 peptides
AMYLIN PHARMACEUTICALS INC63 citations97
US7858740B2Dec 28, 2010
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC39 citations96
US7700549B2Apr 20, 2010
Exendin agonist analogs to treat diabetes
AMYLIN PHARMACEUTICALS INC43 citations96
US7683030B2Mar 23, 2010
Methods of treating diabetes with albumin-conjugated exendin peptides
AMYLIN PHARMACEUTICALS INC42 citations96
US7608692B2Oct 27, 2009
Exendins and exendin agonists modified with albumin
AMYLIN PHARMACEUTICALS INC43 citations96
US7419952B2Sep 2, 2008
Use of exendins and agonists thereof to treat diabetes
AMYLIN PHARMACEUTICALS INC53 citations96
US7105490B2Sep 12, 2006
Methods and compositions for treating polycystic ovary syndrome
AMYLIN PHARMACEUTICALS INC35 citations96
US6506724B1Jan 14, 2003
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
AMYLIN PHARMACEUTICALS INC177 citations96
US7220721B1May 22, 2007
Exendin agonist peptides
AMYLIN PHARMACEUTICALS INC92 citations94
US7696161B2Apr 13, 2010
Exendin agonist compounds
AMYLIN PHARMACEUTICALS INC43 citations93
US5580953ADec 3, 1996
Amylin antagonist peptides and uses therefor
AMYLIN PHARMACEUTICALS INC41 citations92
US7723471B2May 25, 2010
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AMYLIN PHARMACEUTICALS INC18 citations91
US7452858B2Nov 18, 2008
Treatment of gestational diabetes
AMYLIN PHARMACEUTICALS INC43 citations90
IMMUNEX CORP
3 patentsUS5011912AApr 30, 1991
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
IMMUNEX CORP519 citations98
US4851341AJul 25, 1989
Immunoaffinity purification system
IMMUNEX CORP224 citations98
US5028423AJul 2, 1991
Immunogenic conjugates comprising leukotoxin peptide fragments
IMMUNEX CORP19 citations82